Eutin, Germany

Jutta Wiese

This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Geomar Helmholtz-Zentrum Fur Ozeanforschung Kiel, Helmholtz-Zentrum Fuer Ozeanforschung Kiel (Geomar). Active years: 2014.

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jutta Wiese: Innovator in Antitumoral Research

Introduction

Jutta Wiese is a prominent inventor based in Eutin, Germany. She has made significant contributions to the field of antitumoral research, particularly through her innovative work on cyclodepsipeptides. With a total of 2 patents, her inventions are paving the way for new therapeutic approaches.

Latest Patents

Wiese's latest patents include the "Production and use of antitumoral cyclodepsipeptides," which focuses on a compound with a specific general structure. Another notable patent is the "Production and use of antitumoral antibiotic and insecticidal cyclodepsipeptides," which describes a compound where R can be a hydrogen atom or various forms of alkyl and phenyl groups. These patents highlight her dedication to developing effective treatments against cancer.

Career Highlights

Throughout her career, Jutta Wiese has worked with esteemed institutions such as the Helmholtz-Zentrum für Ozeanforschung Kiel and GEOMAR Helmholtz-Zentrum für Ozeanforschung Kiel. Her research has been instrumental in advancing the understanding of cyclodepsipeptides and their potential applications in medicine.

Collaborations

Wiese has collaborated with notable colleagues, including Johannes Imhoff and Gerhard Lang. These partnerships have enriched her research and contributed to the success of her innovative projects.

Conclusion

Jutta Wiese's work in antitumoral research exemplifies the impact of innovation in the medical field. Her patents and collaborations reflect her commitment to advancing cancer treatment through scientific discovery.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…